| | ||||||||
| "anti diabetes" | ||||||||
| NEWS | ||||||||
Sensex Drifts Lower Ahead Of F&O Expiry Glenmark Pharmaceuticals tumbled 5 percent after the Delhi High Court restrained the company from manufacturing and marketing its anti-diabetes ...
| ||||||||
| You have received this email because you have subscribed to Google Alerts. |
Receive this alert as RSS feed |
| Send Feedback |
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.